155 related articles for article (PubMed ID: 31279989)
41. Preliminary analysis: Background parenchymal 18F-FDG uptake in breast cancer patients appears to correlate with background parenchymal enhancement and to vary by distance from the index cancer.
Kim E; Mema E; Axelrod D; Sigmund E; Kim SG; Babb J; Melsaether AN
Eur J Radiol; 2019 Jan; 110():163-168. PubMed ID: 30599855
[TBL] [Abstract][Full Text] [Related]
42. Diffusion-weighted imaging: Effects of intravascular contrast agents on apparent diffusion coefficient measures of breast malignancies at 3 Tesla.
Nguyen VT; Rahbar H; Olson ML; Liu CL; Lehman CD; Partridge SC
J Magn Reson Imaging; 2015 Sep; 42(3):788-800. PubMed ID: 25611726
[TBL] [Abstract][Full Text] [Related]
43. Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors.
Joo I; Lee JM; Han JK; Yang HK; Lee HJ; Choi BI
J Magn Reson Imaging; 2015 Jun; 41(6):1608-14. PubMed ID: 25044978
[TBL] [Abstract][Full Text] [Related]
44. Background parenchymal enhancement and its effect on lesion detectability in ultrafast dynamic contrast-enhanced MRI.
Honda M; Kataoka M; Iima M; Miyake KK; Ohashi A; Kishimoto AO; Ota R; Nickel MD; Toi M; Togashi K
Eur J Radiol; 2020 Aug; 129():108984. PubMed ID: 32534350
[TBL] [Abstract][Full Text] [Related]
45. [Comparison of the Diagnostic Values of Dynamic Enhanced Magnetic Resonance Imaging,Digital Breast Tomosynthesis,and Digital Mammography for Early Breast Cancer].
Xu AQ; Weng XB; Zheng J; Li ZQ; Wang XL; Zhang SJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):667-672. PubMed ID: 31699198
[TBL] [Abstract][Full Text] [Related]
46. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
[TBL] [Abstract][Full Text] [Related]
47. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
48. Gadobutrol in the central nervous system at three doses: results from a phase II, randomized, multicenter trial.
Breuer J; Gutierrez J; Latchaw R; Lehr R; Sorensen AG
J Magn Reson Imaging; 2014 Feb; 39(2):410-8. PubMed ID: 23681501
[TBL] [Abstract][Full Text] [Related]
49. Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI.
Avendano D; Marino MA; Leithner D; Thakur S; Bernard-Davila B; Martinez DF; Helbich TH; Morris EA; Jochelson MS; Baltzer PAT; Clauser P; Kapetas P; Pinker K
Breast Cancer Res; 2019 Dec; 21(1):136. PubMed ID: 31801635
[TBL] [Abstract][Full Text] [Related]
50. Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer.
Gilbert FJ; van den Bosch HC; Petrillo A; Siegmann K; Heverhagen JT; Panizza P; Gehl HB; Pediconi F; Diekmann F; Peng WJ; Ma L; Sardanelli F; Belli P; Corcione S; Zechmann CM; Faivre-Pierret M; Martincich L
J Magn Reson Imaging; 2014 May; 39(5):1272-86. PubMed ID: 25006633
[TBL] [Abstract][Full Text] [Related]
51. Effect of IV Administration of a Gadolinium-Based Contrast Agent on Breast Diffusion-Tensor Imaging.
Scaranelo AM; Degani H; Grobgeld D; Talbot N; Bodolai K; Furman-Haran E
AJR Am J Roentgenol; 2020 Oct; 215(4):1030-1036. PubMed ID: 32755227
[No Abstract] [Full Text] [Related]
52. Compressed Sensing for Breast MRI: Resolving the Trade-Off Between Spatial and Temporal Resolution.
Vreemann S; Rodriguez-Ruiz A; Nickel D; Heacock L; Appelman L; van Zelst J; Karssemeijer N; Weiland E; Maas M; Moy L; Kiefer B; Mann RM
Invest Radiol; 2017 Oct; 52(10):574-582. PubMed ID: 28463932
[TBL] [Abstract][Full Text] [Related]
53. Does injection flow rate have an impact on arterial phase image degradation in liver MRI? A comparison of gadoxetic acid versus gadobutrol.
Cohen-Hallaleh V; Guo L; Hosseini-Nik H; Razaghi Kashani N; Menezes R; Jhaveri K
Clin Radiol; 2017 Nov; 72(11):994.e1-994.e8. PubMed ID: 28673445
[TBL] [Abstract][Full Text] [Related]
54. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
[TBL] [Abstract][Full Text] [Related]
55. Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
Kim SY; Cho N; Park IA; Kwon BR; Shin SU; Kim SY; Lee SH; Chang JM; Moon WK
Radiology; 2018 Nov; 289(2):327-334. PubMed ID: 30152744
[TBL] [Abstract][Full Text] [Related]
56. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions.
Ma D; Lu F; Zou X; Zhang H; Li Y; Zhang L; Chen L; Qin D; Wang B
Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437
[TBL] [Abstract][Full Text] [Related]
57. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
[TBL] [Abstract][Full Text] [Related]
58. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
60. Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K; Bogner W; Baltzer P; Gruber S; Bickel H; Brueck B; Trattnig S; Weber M; Dubsky P; Bago-Horvath Z; Bartsch R; Helbich TH
Invest Radiol; 2014 Jun; 49(6):421-30. PubMed ID: 24566292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
